BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34015327)

  • 1. A Case Report on Type 2 Amiodarone Induced Thyrotoxicosis and Hypercalcemia.
    Ganesan K; Bradley B; Jones DW; Solomon DS
    Am J Med Sci; 2021 Sep; 362(3):308-313. PubMed ID: 34015327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-induced type 2 thyrotoxicosis.
    Portelli D; Mifsud S; Abela A; Fava S
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33419749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
    Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
    Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
    Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
    Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study.
    Bogazzi F; Bartalena L; Cosci C; Brogioni S; Dell'Unto E; Grasso L; Aghini-Lombardi F; Rossi G; Pinchera A; Braverman LE; Martino E
    J Clin Endocrinol Metab; 2003 May; 88(5):1999-2002. PubMed ID: 12727944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amiodarone and the thyroid gland].
    Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
    Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
    Liang YL; Huang SM; Peng SL; Hsiao SH; Hung HC; Ou HY; Wu TJ
    Ann Pharmacother; 2009 Jan; 43(1):134-8. PubMed ID: 19109209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone-induced thyroid dysfunction.
    Danzi S; Klein I
    J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
    Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
    J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone and thyroid dysfunction.
    Padmanabhan H
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome.
    Conen D; Melly L; Kaufmann C; Bilz S; Ammann P; Schaer B; Sticherling C; Muller B; Osswald S
    J Am Coll Cardiol; 2007 Jun; 49(24):2350-5. PubMed ID: 17572251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
    Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease--a cohort study.
    Stan MN; Ammash NM; Warnes CA; Brennan MD; Thapa P; Nannenga MR; Bahn RS
    Int J Cardiol; 2013 Aug; 167(3):821-6. PubMed ID: 22386642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
    Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
    Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of amiodarone-iodine-induced thyrotoxicosis(AIIT) associated with severe nonthyroidal illness.
    Balzano S; Sau F; Bartalena L; Ruscazio M; Balestrieri A; Cherchi A; Martino E
    J Endocrinol Invest; 1987 Dec; 10(6):589-91. PubMed ID: 3440824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
    Bogazzi F; Bartalena L; Tomisti L; Rossi G; Tanda ML; Dell'Unto E; Aghini-Lombardi F; Martino E
    J Clin Endocrinol Metab; 2007 Feb; 92(2):556-62. PubMed ID: 17148557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propylthiouracil-induced interstitial pneumonia in a Caucasian woman with amiodarone-induced thyrotoxicosis.
    Diazzi C; Brigante G; Rossi G; Rochira V
    Thyroid; 2012 Mar; 22(3):325-9. PubMed ID: 22313427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone-induced thyrotoxicosis in children and adolescents is a possible outcome in patients with low iodine intake.
    Hacihamdioğlu B; Berberoğlu M; Siklar Z; Savaş Erdeve S; Oçal G; Tutar E; Atalay S
    J Pediatr Endocrinol Metab; 2010 Apr; 23(4):363-8. PubMed ID: 20583541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.